|
| Results | All patients | Iodine allergic patients |
|
| Endoscopic procedure included, no | 2295 | 127 |
| Post-ERCP anaphylaxis | | |
| (i) Yes, no (%) | 0 (0.0) | 0 (0.0) |
| (ii) No, no (%) | 2294 (99.9) | 127 (100.0) |
| (iii) Not available, no (%) | 1 (0.04) | - |
| Reported allergic reaction | | |
| (i) Yes, no (%) | 1 (0.0004) | 0 (0.0) |
| (ii) No, no (%) | 2294 (99.9) | 127 (100.0) |
| Contrast induced adverse reaction | | |
| (i) Rash, pruritus, no (%) | 1 (0.0004) | 0 (0.0) |
| (ii) Other, no (%) | 0 (0.0) | 0 (0.0) |
| ERCP details | | |
| (i) Cholangiography, no (%) | - | 124 (97.6) |
| (ii) Pancreatography, no (%) | - | 66 (51.9) |
| (iii) Sphincterotomy, no (%) | - | 67 (52.7) |
| (iv) Lithiasis extraction, no (%) | - | 49 (38.5) |
| (v) Stent placement, no (%) | - | 61 (48.0) |
| (vi) Biliary biopsy, no (%) | - | 16 (12.6) |
| (vii) Brush cytology, no (%) | - | 10 (7.8) |
| Contrast media | | |
| (i) Omnipaque 240, no (%) | - | 105 (82.7) |
| (ii) Visipaque 320, no (%) | - | 19 (15.0) |
| (iii) Visipaque 270, no (%) | - | 3 (2.4) |
| Observation period | | |
| (i) 4 hours and less, no (%) | - | 47 (37.0) |
| (ii) 4 to 24 hours, no (%) | - | 20 (15.7) |
| (iii) More than a day, no (%) | - | 60 (47.2) |
|
